A Case Study: Early-stage biopharmaceutical company
About the client:
CureDM is an early-stage biopharmaceutical company developing new therapies to reverse diabetes. Their research was innovative and ground-breaking, but they knew that in order to begin presenting at the corporate level, they needed a new professional look in order to compete with other early-stage companies in their industry. They needed a redesign of their corporate identity and communication materials that reflected their marketing strategy and desired corporate image, with the goal of present a compelling case to their potential investors/buyers.
The work we did for the client:
• Corporate identity system
• Website
• PPT presentation template
• Print collateral
The results:
One of the most innovative global pharmaceutical companies, Sanofi-Aventis, acquired the exclusive worldwide rights to manufacture, develop and market CureDM’s PancreateTM (proisletide acetate), for the treatment of diabetes in human and veterinary applications.
